Background: In recent years, there has been increasing research interest in improving diagnostic and management protocols in childhood arterial ischaemic stroke (AIS). However, childhood stroke comprises, in approximately equal parts, both arterial ischaemic and haemorrhagic stroke (HS).
Introduction
Childhood stroke occurs with an incidence of 1,3-8/100 000 children/year, approximately as often as brain tumours, and is among the top ten of mortality in children [1] [2] [3] [4] . Primary strokes may be either arterial ischaemic strokes (AIS) that are caused by a blocked arterial supply or venous (= cerebral venous sinus thrombosis) or haemorrhagic, when they are defined as nontraumatic spontaneous intracranial bleeding. There has been increasing research activity in the field of childhood arterial ischaemic stroke in recent years: Understanding the underlying pathological mechanisms (e.g. focal cerebral arteriopathy), acute treatment options (e.g. iv thrombolysis and mechanical thrombectomy) and reducing the time gap between clinical onset and diagnosis by using appropriate imaging modalities are examples of ongoing research [5] [6] [7] [8] [9] [10] [11] . There has been less research interest in and awareness of haemorrhagic stroke (HS), although it accounts for almost half of all childhood strokes.
Therefore, we aimed to describe a paediatric cohort with HS with respect to clinical presentation, aetiology and short-term outcome and point out the differences to childhood AIS. These data could support paediatricians in their clinical assessment and diagnostic investigation of children presenting with possible HS.
Method
We performed a retrospective review of electronic medical records of children with haemorrhagic stroke in a tertiary university children`s hospital in Munich, Germany between January 2010 -December 2016. This university children`s hospital provides, together with another university hospital and two other children`s hospitals, acute medical advice for 231.510 children from 0-18 years (overall population of Munich in 2017: 1.456.039) 12 .
Inclusion criteria was the diagnosis of an haemorrhagic stroke defined as spontaneous, nontraumatic intracranial bleeding (intraparenchymal, ventricular or subarachnoid) in children and adolescents (≥28 days of life ≤18 years). As it remains unclear whether children who bleed in a brain tumour are subsumed under the term `haemorrhagic stroke`, we decided only to include those patients with a brain tumour, who bled into brain parenchyma, ventricles or subarachnoid space. Exclusion criteria were perinatal / neonatal haemorrhage (<28 days of life), primary subdural or epidural bleeding, traumatic intracranial bleeding, haemorrhagic transformation of AIS or secondary HS due to a venous infarction.
Patients eligible for inclusion were identified via ICD-10 codes (international classification of diseases) given by the treating paediatrician. In order to ensure as complete data collection as possible, we used a broad spectrum of ICD-10 codes (see table 1 ).
In total, 290 children were identified applying the abovementioned ICD-10 criteria and their electronic medical records were further reviewed to see whether they met the inclusionexclusion criteria as shown in figure 1.
Collected information included demographic data, clinical presentation, aetiology, imaging modality, acute treatment and short-term outcome with respect to discharge from hospital.
Ethical approval
The study was approved by the ethics committee and data protection commissioner of the Medical Faculty of the Ludwig-Maximilians-University Munich, Nr 756-16 (06-12-16).
Results

Patients
The study group consisted of 25 patients. Sex ratio was m:f = 0.8:1. Median age at the time of bleeding was 8 years 1month (range 1 month -16years 9months) .
Clinical presentation
The presenting features of the children are presented in tables 2 and 3.
Most children presented with vomiting (48%), headache (40%) and altered level of consciousness (32%), followed by seizures (28%) brainstem symptoms (16%), and acute hemiparesis (12%). One child, receiving extracorporeal mebrane oxygenation on the intensive care unit, showed signs of increased intracranial pressure. All three infants (i.e. and atypical teratoid/rhabdoid tumour (ATRT).
There were two patients with an underlying coagulopathy: one had idiopathic thrombocytopenic purpura (thrombocyte count 3000/ microliter) and the other had Vitamin K deficiency due to infantile obstructive cholangiopathy. Both patients with coagulopathy were younger than one year.
Other aetiologies included severe acute infection (Herpes simplex virus (HSV) encephalitis) (n=1), chronic lung disease of unknown aetiology with multiorgan failure in the course of a septic shock (n=1) and haemato-oncological diseases (n=2; hepatocellular carcinoma with brain metastases (n=1), acute myeloid leukaemia, pulmonary invasive aspergillosis with need of cardiopulmonary resuscitation (n=1)). In one child, the underlying aetiology for the spontaneous ventricular bleeding remained unclear besides extensive diagnostic work-up including computed tomography (CT), CT angiography, magnetic resonace angiography (MRA), conventional cerebral angiography (CCA) and laboratory testing for coagulation problems and vasculitis.
With respect to number of risk factors, 20 patients had a single risk factor, four patients had a severe underlying disease with in the clinical course presumed multiple risk factors and one child had no known risk factor.
Treatment
Treatment decision was based on the initial presentation of the child and underlying aetiology. 17 patients underwent neurosurgical intervention, one patient endovascular (embolization of an AVM) and seven children conservative treatment.
Short-term Outcome
In our cohort two patients died. Both patients suffered from a severe underlying disease (severe chronic lung disease and infantile obstructive cholangiopathy) with intracranial bleeding as a result of an extremely complicated course of the primary disease. Most patients could be discharged home (n=18). Five children had further in-hospital treatments or were transferred to a rehabilitation clinic.
Neurological examination at time of discharge was normal in 13 children. Neurological deficits in the other patients were hemiparesis ± facial palsy (n=8), ataxia (n=1), speech disturbance (n=1) and impaired short-term memory (n=1). One patient had multiple severe neurological sequelae after a brainstem bleeding. One small infant showed no neurological deficit but had a poor prognosis due to a malignant brain tumour (ATRT) without response to chemotherapy. Our collected data do not provide any information about long-term outcome.
Discussion
Treatment of children with HS is not only the preserve of neurosurgeons and interventional neuroradiologists and should involve paediatricians/paediatric neurologists. It is the paediatrician`s responsibility as the first medical contact to know when to think about HS and what to do as the first diagnostic steps in uncovering the most likely underlying aetiologies.
In our cohort, most children presented with vomiting, headache and an altered level of consciousness. This result is similar to literature where headache is one of the main presenting symptom [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Headache is very frequently reported in children and adolescents in the general population and is one of the most common reasons for patients seeking medical advice from paediatricians. Sometimes it may be difficult to decide which child with headache needs more extensive investigations because they may have intracranial bleeding.
However, as de Ribaupierre et al suggest, every headache that is described as "worst"
and/or has a "sudden" onset as well as every headache with concomitant focal neurological deficits should immediately lead to further investigations 17 .
In younger children in whom headache may/could not be the leading (communicated) symptom, the clinical presentation of haemorrhagic stroke may be more nonspecific. With respect to the underlying risk factors, our study concurs with the published literature: vascular diseases are the predominant risk factor for intracranial bleeding in a paediatric population (52% in our study vs 7-91% in the literature) [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . In our cohort, vascular malformation were more common in elder children and were not present in the first year of life. This is a relevant information with reference to the required diagnostic work up, as investigation for coagulation problems, infections and malignancies (including brain tumours) then becomes more important in the younger age group. Aneurysms, as one of the three main vascular risk factors besides AVM and cavernoma, were not described in our cohort, probably due to the small cohort size. In some children, intracranial haemorrhage is described as the initial symptom of a brain tumour 18, 20 . The definition of haemorrhagic stroke related to a brain tumour is imprecise and not consistent. We decided to exclude patients who bled into a brain tumour (n=8) and only described patients with a brain tumour who bled into brain parenchyma, the ventricles or subarachnoid space (n=5). One study with high percentages of children with brain tumour as an underlying aetiology included patients who had bled into a brain tumour 18 . One other study did not provide clear information about whether haemorrhage was into or outside the brain tumour, merely describing it as being associated with a brain tumour 20 . Nevertheless, the proportion of children with a brain tumour as underlying disease (20%) in our cohort remains high compared to other studies (up to 15%). As our university hospital is a center for paediatric oncology and haematology, this may be the reason for the higher percentages compared to non- This was not an epidemiological study and therefore the patient population studied will have been subject to selection biases that influenced their referral to our hospital. For example, Ludwig-Maximilians-University Hospital is a paediatric onclogy centre and the relatively high incidence of malignancy as an underlying cause of HS probably reflects this selction bias.
Other selection biases, like the referral of adolescents to adult stroke units or neurosurgery departments, may be applied, but, we believe that the range of underlying aetiologies that we found reflect the true range even if the proportions may have been different in a population based study.
Our retrospective study only provides data about short-term outcome. At the end of the acute care phase, 52% of the patients had no neurological deficit and 72% could be discharged home. But without using a standardized neurological examination instrument like the Pediatric Stroke Outcome Measure (PSOM) and because of missing short-or long-term follow up data, these results are barely comparable to other studies. Beslow et al found an abnormal neurological examinationa after a median follow up time of 3.5 months in 71% of children after HS 15 . Recently, a rehabilitation center-based retrospective study focused on long-term outcome of 128 children after childhood AIS and HS. In general, they saw better motor neurological, functional and academic outcomes after HS (versus AIS) at time of discharge from the rehabilitation department 26 . However, at time of discharge (median time since stroke of 4.7 months), 59.3% of children with HS showed some degree of motor deficit and 35.8% required special education after a median follow-up period of 43 months.
Further prospective studies or registry based data are required to capture all children with childhood HS in order to describe accurately long-term outcomes and how these outcomes are influenced by underlying aetiology, acute treatment and rehabilitative treatment after discharge from the acute hospital setting. 
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